Christopher G. Dowson

15.0k total citations
156 papers, 10.3k citations indexed

About

Christopher G. Dowson is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Christopher G. Dowson has authored 156 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Epidemiology, 39 papers in Molecular Biology and 36 papers in Infectious Diseases. Recurrent topics in Christopher G. Dowson's work include Pneumonia and Respiratory Infections (41 papers), Antibiotic Resistance in Bacteria (35 papers) and Antimicrobial Resistance in Staphylococcus (26 papers). Christopher G. Dowson is often cited by papers focused on Pneumonia and Respiratory Infections (41 papers), Antibiotic Resistance in Bacteria (35 papers) and Antimicrobial Resistance in Staphylococcus (26 papers). Christopher G. Dowson collaborates with scholars based in United Kingdom, United States and Canada. Christopher G. Dowson's co-authors include Brian G. Spratt, Tracey J. Coffey, Eshwar Mahenthiralingam, Adrian M. Whatmore, Amy Baldwin, John Maynard Smith, M. Daniels, A.D.M. Rayner, Lynne Boddy and David I. Roper and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Christopher G. Dowson

155 papers receiving 9.9k citations

Peers

Countries citing papers authored by Christopher G. Dowson

Since Specialization

Citations

This map shows the geographic impact of Christopher G. Dowson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. Dowson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. Dowson more than expected).

Fields of papers citing papers by Christopher G. Dowson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher G. Dowson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. Dowson. The network helps show where Christopher G. Dowson may publish in the future.

Co-authorship network of co-authors of Christopher G. Dowson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. Dowson. A scholar is included among the top collaborators of Christopher G. Dowson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. Dowson. Christopher G. Dowson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery and chemical optimisation of a potent, Bi-cyclic antimicrobial inhibitor of Escherichia coli PBP3 2025 ·Communications Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Steven J. Stanway, (unknown), (unknown), Katerine Van Rietschoten, Dom Bellini, David I. Roper, Adrian J. Lloyd, Christopher G. Dowson, Michael J. Skynner, Paul Beswick, Michael J. Dawson	1
2	A conserved zinc-binding site in Acinetobacter baumannii PBP2 required for elongasome-directed bacterial cell shape 2023 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), Ralph R. Isberg, Christopher G. Dowson, Adrian J. Lloyd, Edward Geisinger, Allister Crow, David I. Roper	10
3	Plant peptidoglycan precursor biosynthesis: Conservation between moss chloroplasts and Gram-negative bacteria 2022 ·PLANT PHYSIOLOGY ·Mandy Dowson-Day, Adrian J. Lloyd, Andrew C. Cuming, David I. Roper, Lorenzo Frigerio, Christopher G. Dowson	9
4	A molecular link between cell wall biosynthesis, translation fidelity, and stringent response in Streptococcus pneumoniae 2021 ·Proceedings of the National Academy of Sciences ·(unknown), Adrian J. Lloyd, Saigopalakrishna S. Yerneni, (unknown), Jennifer N. Shepherd, David I. Roper, Christopher G. Dowson, Sérgio R. Filipe, N. Luisa Hiller	12
5	Substrate and Stereochemical Control of Peptidoglycan Cross-Linking by Transpeptidation by Escherichia coli PBP1B 2020 ·Journal of the American Chemical Society ·(unknown), Adrian J. Lloyd, (unknown), (unknown), Susan E. Slade, (unknown), (unknown), (unknown), (unknown), Dean Rea, Neil D. Evans, Michael J. Chappell, David I. Roper, Christopher G. Dowson	18
6	Investigating Bacteriophages Targeting the Opportunistic Pathogen Acinetobacter baumannii 2020 ·Antibiotics ·(unknown), Rapee Thummeepak, Udomluk Leungtongkam, (unknown), (unknown), Andrew Millard, John Moat, Christopher G. Dowson, Elizabeth M. H. Wellington, Sutthirat Sitthisak, Antonia P. Sagona	32
7	Structure-Guided Enhancement of Selectivity of Chemical Probe Inhibitors Targeting Bacterial Seryl-tRNA Synthetase 2019 ·Journal of Medicinal Chemistry ·Ricky Cain, (unknown), (unknown), Dom Bellini, Colin W. G. Fishwick, Lloyd G. Czaplewski, David J. Scott, Gemma Harris, Christopher G. Dowson, Adrian J. Lloyd, David I. Roper	13
8	Bacterial Lipid II Analogs: Novel In Vitro Substrates for Mammalian Oligosaccharyl Diphosphodolichol Diphosphatase (DLODP) Activities 2019 ·Molecules ·(unknown), Michaël Bosco, Isabelle Chantret, Thibaut Léger, (unknown), David I. Roper, Christopher G. Dowson, Patricia Busca, Ahmed Bouhss, Christine Gravier‐Pelletier, Stuart Moore	1
9	Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine 2017 ·Nature Communications ·Sarah Batson, Cesira de Chiara, (unknown), Adrian J. Lloyd, Stanislav Gobec, Dean Rea, Vilmos Fülöp, (unknown), Katie J. Simmons, Christopher G. Dowson, Colin W. G. Fishwick, Luiz Pedro S. de Carvalho, David I. Roper	65
10	Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis 2017 ·Nature Communications ·Anh Tran, Emma E. Watson, Venugopal Pujari, Trent Conroy, Luke J. Dowman, Andrew M. Giltrap, Angel Pang, Weng Ruh Wong, Roger G. Linington, Sebabrata Mahapatra, Jessica Saunders, Susan A. Charman, Nicholas P. West, Timothy D. H. Bugg, (unknown), Christopher G. Dowson, David I. Roper, Dean C. Crick, Warwick J. Britton, Richard J. Payne	40
11	In vitro characterization of the antivirulence target of Gram-positive pathogens, peptidoglycan O-acetyltransferase A (OatA) 2017 ·PLoS Pathogens ·David Sychantha, (unknown), Dustin J. Little, Patrick J. Moynihan, Howard Robinson, (unknown), David I. Roper, Christopher G. Dowson, P. Lynne Howell, Anthony J. Clarke	35
12	Validation of the Bladder Control Self –Assessment Questionnaire (B-SAQ) in men 2012 ·Arun Sahai, Eduardo Cortes, Jai Seth, Christopher G. Dowson, Jane Watkins, (unknown), Prokar Dasgupta, Linda Cardozo, Christopher R. Chapple, (unknown)	2
13	Overactive bladder in men: initial assessment 2012 ·Trends in Urology & Men s Health ·(unknown), Christopher G. Dowson, Jai Seth, Muhammad Shamim Khan, Prokar Dasgupta, Arun Sahai	0
14	The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trial 2011 ·International Journal of Clinical Practice ·Christopher G. Dowson, Arun Sahai, John G. Watkins, Prokar Dasgupta, (unknown)	28
15	VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers 2009 ·Health Technology Assessment ·Jo C Dumville, Gill Worthy, Marta Soares, (unknown), Nicky Cullum, Christopher G. Dowson, C Iglesias, Dorothy McCaughan, (unknown), E Andrea Nelson, David Torgerson	59
16	A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers 2006 ·Health Technology Assessment ·E Andrea Nelson, Susan O’Meara, Dawn Craig, C Iglesias, Su Golder, Jane Dalton, K Claxton, Sally EM Bell-Syer, Edward B. Jude, Christopher G. Dowson, Roger Gadsby, Paul O’Hare, Janet T. Powell	171
17	Fluorescent reagents for in vitro studies of lipid-linked steps of bacterial peptidoglycan biosynthesis: derivatives of UDPMurNAc-pentapeptide containing d -cysteine at position 4 or 5 2006 ·Molecular BioSystems ·James Schouten, (unknown), Adrian J. Lloyd, Gianfranco De Pascale, Christopher G. Dowson, David I. Roper, Timothy D. H. Bugg	28
18	IFN-γ Enhances Production of Nitric Oxide from Macrophages via a Mechanism That Depends on Nucleotide Oligomerization Domain-2 2006 ·The Journal of Immunology ·Sabine Tötemeyer, Mark Sheppard, Adrian J. Lloyd, David I. Roper, Christopher G. Dowson, David M. Underhill, Peter J. Murray, Duncan J. Maskell, Clare Bryant	68
19	Deletion analysis of the essentiality of penicillin-binding proteins 1A, 2B and 2X ofStreptococcus pneumoniae 1993 ·FEMS Microbiology Letters ·(unknown), Umender Sharma, Christopher G. Dowson, (unknown), Tanjore S. Balganesh, Brian G. Spratt	65
20	Penicillin‐binding protein 2 genes of non‐β‐lactamase‐producing, penicillin‐resistant strains of Neisseria gonorrhoeae 1989 ·Molecular Microbiology ·Christopher G. Dowson, A E Jephcott, (unknown), Brian G. Spratt	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact